My NCBI | Sign In
RSS Settings
  • Search: Serdarevic-Pehar M[au]

Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 3

    1.

    Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.

    Barnett AH, Lange P, Dreyer M, Serdarevic-Pehar M; Exubera Phase 3 Study Group.

    Int J Clin Pract. 2007 Oct;61(10):1614-25. Erratum in: Int J Clin Pract. 2008 Jan;62(1):171. PMID: 17877648 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.

    Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

    Diabetes Care. 2006 Aug;29(8):1818-25.PMID: 16873786 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

    Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

    Diabetes Care. 2006 Jun;29(6):1282-7.PMID: 16732009 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity